Li, Guoling

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects

Tong, H., Huang, J., Xiao, Q., He, B., Dong, X., Liu, Y., Yang, X., Han, D., Wang, Z., Wang, X., et al. (2023) · Nature Biotechnology

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 230

Mini-dCas13X–mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy

Li, G., Jin, M., Li, Z., Xiao, Q., Lin, J., Yang, D., Liu, Y., Wang, X., Xie, L., Ying, W., et al. (2023) · Journal of Clinical Investigation

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 44

Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitation

Zhou, Y., Li, G., Dong, X., Luo, J., Li, T., Zhao, G., Zhang, H., Zhou, J., Cui, S., Zeng, Z., et al. (2024) · Nature Communications

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 9

Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitation

Li, G., Dong, X., Luo, J., Yuan, T., Li, T., Zhao, G., Zhang, H., Zhou, J., Zeng, Z., Cui, S., et al. (2024) · Nature Communications

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 9